竹下 勝

Medicine & Life Sciences

1. Rheumatoid Arthritis 100%
2. SARS Virus 55%
3. T-Lymphocytes 45%
4. Neutralizing Antibodies 39%
5. Antibodies 30%
6. Severe Acute Respiratory Syndrome 30%
7. Coronavirus 29%
8. Infliximab 29%
9. Centromere 28%
10. Serum 26%
11. Interstitial Lung Diseases 25%
12. Matrix Metalloproteinase 3 25%
13. Biomarkers 23%
14. Methotrexate 22%
15. Anti-Idiotypic Antibodies 21%
16. Autoantibodies 20%
17. Antigens 19%
18. B-Lymphocytes 18%
19. Vaccination 18%
20. milk fat globule 18%
21. Helper-Inducer T-Lymphocytes 18%
22. Interleukin-16 18%
23. Coronavirus Infections 16%
24. Immunoglobulin G4-Related Disease 16%
25. Cytokines 15%
26. Sendai virus 15%
27. Kinetochores 15%
28. Genes 14%
29. Immune Evasion 14%
30. Etanercept 14%
31. Salivary Glands 14%
32. Autoantigens 14%
33. Interleukin-6 14%
34. Th2 Cells 13%
35. Drug Monitoring 13%
36. Autoimmune Diseases 13%
37. Alveolar Epithelial Cells 13%
38. HLA-DR Antigens 12%
39. Monocytes 12%
40. Infections 11%
41. Synovial Fluid 11%
42. Epidermal Growth Factor 11%
43. Thymus Gland 11%
44. Systemic Lupus Erythematosus 11%
45. Polysaccharides 11%
46. Interleukin-4 10%
47. Monoclonal Antibodies 10%
48. Proteomics 10%
49. Immunoglobulin G 10%
50. Synovitis 10%